Evidence map›Paper›PMID 24219102›Full record

SynthesisBritish journal of clinical pharmacology2014

Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review.

Valentina G Dell'Orto, Eva A Belotti, Barbara Goeggel-Simonetti, Giacomo D Simonetti, Gian Paolo Ramelli, Mario G Bianchetti, Sebastiano A G Lava

Registry-linked trialOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in British journal of clinical pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03354507 (Use of Sodium Bicarbonate to Alkalinize Serum/Urine in Pediatric Patients Treated With Topiramate), which is not on this map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
8.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03354507 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Use of Sodium Bicarbonate to Alkalinize Serum/Urine in Pediatric Patients Treated With Topiramate (Pilot Study)

TypeinterventionalSponsorMcMaster Children's HospitalRan2018 to 2018Enrolled40ConditionsEpilepsy, Metabolic Acidosis, Tubular Acidosis, RenalArmsSodium bicarbonate
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Managing Essential Tremor.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. The frequency and severity of metabolic acidosis related to topiramate.The Journal of international medical research · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Valentina G Dell'OrtoDepartment of Pediatrics, San Giovanni Hospital, Bellinzona, Switzerland; University of Berne, Berne, Switzerland.
Eva A Belotti
Barbara Goeggel-Simonetti
Giacomo D Simonetti
Gian Paolo Ramelli
Mario G Bianchetti
Sebastiano A G Lava
Ospedale San Giovanni Bellinzona · CHUniversity Children’s Hospital Bern · CHUniversity of Bern · CHUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe use of topiramate, which is prescribed for the management of epilepsy, for migraine headache prophylaxis and as a weight-loss agent, has been associated with the development of metabolic acidosis, hypokalaemia and renal stone disease. We systematically reviewed all the literature.

methodsThe systematic review of the literature was realized using the principles underlying the UK Economic and Social Research Council guidance on the conduct of narrative synthesis and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.

resultsFourty-seven reports published between 1996 and 2013 were retained for the final analysis. Five case-control studies and six longitudinal studies addressed the effect of topiramate on acid-base and potassium balance. A significant tendency towards mild-to-moderate hyperchloraemic metabolic acidosis (with bicarbonate ≤21.0 mmol l(-1) in approximately every third case) and mild hypokalaemia (with potassium ≤3.5 mmol l(-1) in 10% of the cases) was noted on treatment with topiramate, which was similar in children and adults. A single study observed that topiramate causes mild hyperuricaemia in male adults. A tendency towards hypocitraturia, a recognized promoter of renal stone formation, was noted in all patients on topiramate.

conclusionsIncreasing evidence supports the use of topiramate. Topiramate is generally well tolerated, and serious adverse events are rare. Nonetheless, the present systematic review of the literature indicates that its use is linked with the development of acidosis, hypokalaemia, hyperuricaemia and hypocitraturia.

Indexed as

AcidosisFemaleFructoseHumansHypokalemiaKidney CalculiMaleTopiramateFructoseTopiramateAcidosiscitraturiahyperuricaemiahypokalaemiarenal stone promotiontopiramate

Identifiers

PMID24219102
PMCPMC4093921
OpenAlexW1529190035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.